Drug combination sidesteps resistance in aggressive childhood neuroblastoma models
A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at the Garvan Institute of Medical Research in Sydney, Australia, found a drug combination that can bypass the cellular defenses these tumors develop that lead to relapse. Read more: https://medicalxpress.com/news/2025-11-drug-combination-sidesteps-resistance-aggressive.html
Dec 9, 2025
Why Childhood Cancer Survivors Are at Higher Risk of Colorectal Cancer — and What Their Doctors Can Do About It
Ajay Major, MD, MBA, led a research study that found that childhood cancer survivors were diagnosed with subsequent colorectal cancer at younger ages than expected and had high mortality rates after a colorectal cancer diagnosis. Read more: https://news.cuanschutz.edu/cancer-center/childhood-cancer-survivors-higher-risk-colorectal-cancer
Dec 8, 2025
Researchers Highlight Genetic Factors in Pediatric Brain and Spinal Cord Tumors
Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering how rare inherited genetic variants contribute to the development of brain and spinal cord tumors in children. Read more: https://www.prnewswire.com/news-releases/researchers-highlight-genetic-factors-in-pediatric-brain-and-spinal-cord-tumors-302623472.html
Dec 5, 2025
Science on shaky ground: Canadian research shifts in the wake of US cuts
For Whitlock and other Canadian scientists who have collaborations with US partners, the past ten months have been turbulent. With US scientific agencies such as the NIH, the National Oceanic and Atmospheric Administration (NOAA) and the Environmental Protection Agency (EPA) seeing billions of dollars in funding cuts and job losses under the administration of US President Donald Trump, the effects have also been felt in Canada. There, cancelled projects and uncertainty have c
Dec 4, 2025
Exploring the survival tactics of childhood cancers
Lava-dwelling lizards, cells playing dead and a century-old evolutionary theory – understanding the way childhood cancers resist treatment is proving to be quite a ride. Read more: https://news.cancerresearchuk.org/2025/11/18/exploring-the-hidden-survival-tactics-of-childhood-cancers/
Dec 3, 2025
Food insecurity linked to tumor growth in pediatric neuroblastoma
Despite major therapeutic advances, survival rates remain lower for children from socioeconomically disadvantaged families, a pattern long observed and poorly understood at the biological level. Read more: https://medicalxpress.com/news/2025-11-food-insecurity-linked-tumor-growth.html
Dec 2, 2025
Ultrasound-Driven Microbubbles Cross Blood-Brain Barrier to Treat Childhood Cancer
Ultrasound-created microbubbles can deliver anti-cancer drugs to tumors in difficult-to-reach areas such as the brain stem and spinal cord, a pilot study in children has revealed. Read more: https://www.insideprecisionmedicine.com/topics/oncology/ultrasound-driven-microbubbles-cross-blood-brain-barrier-to-treat-childhood-cancer/
Dec 1, 2025
Gates calls on Ford government to support families facing pediatric cancer
MPP Wayne Gates (Niagara Falls) rose in the Ontario legislature to call for the Ontario government to take a first step to eliminate hospital parking fees by listening to families dealing with childhood cancer. Gates has partnered with Ontario Parents Advocating for Children with Cancer , the parent voice for families who have children diagnosed with cancer across the province, to fight for this change. Read more: https://www.notllocal.com/local-news/gates-calls-on-ford-gover
Nov 28, 2025
Mystery of treatment-resistant childhood leukemia uncovered
A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukaemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give hope to children and families worldwide. Read more: https://www.eurekalert.org/news-releases/1105676
Nov 26, 2025
Finding the balance between efficacy and toxicity in pediatric cancer treatment
Cancer treatment balances on a razor’s edge. On one side, physicians must use enough of a drug to kill tumor cells effectively. On the other side, a high drug concentration can be harmful to a patient’s normal cells. In children, the difference between the two, called the therapeutic index, is small. Read more: https://www.stjude.org/research/progress/2025/finding-balance-between-efficacy-and-toxicity-in-pediatric-cancer-treatment.html
Nov 25, 2025

